Table 3.
Baseline characteristics in patients with mild-to-moderate AD and the overall THIN population in 2017a
| Baseline characteristic | Overall THIN population n (%) |
Mild-to-moderate AD patients n (%) |
Prevalence of mild-to-moderate AD among the overall THIN population (%) |
|---|---|---|---|
| Overall | 2,639,991 (100%) | 33,749 (100%) | 1.28 |
| Age 0–7 | 203,148 (7.70%) | 10,377 (30.75%) | 5.11 |
| Age 8–11 | 126,173 (4.78%) | 2254 (6.68%) | 1.79 |
| Age 12–17 | 166,442 (6.30%) | 2525 (7.48%) | 1.52 |
| Age 18 + | 2,144,228 (81.22%) | 18,593 (55.09%) | 0.87 |
| Male | 1,320,423 (50.02%) | 15,199 (45.04%) | 1.15 |
| Female | 1,319,568 (49.98%) | 18,550 (54.96%) | 1.41 |
| England | 1,033,047 (39.13%) | 14,440 (42.79%) | 1.40 |
| Northern Ireland | 230,844 (8.74%) | 2478 (7.34%) | 1.07 |
| Scotland | 790,909 (29.96%) | 7735 (22.92%) | 0.98 |
| Wales | 585,191 (22.17%) | 9096 (26.95%) | 1.55 |
AD patients were propensity score matched with up to three non-AD controls based on demographics including age, sex, socio-economic status and practice ID
AD atopic dermatitis, THIN The Health Improvement Network